bibliographic entry 1782509 [be/1782509]
https://w3id.org/oc/corpus/be/1782509

is a

• bibliographic reference

content

• Vey, N, Bourhis, JH, Boissel, N, Bordessoule, D, Prebet, T, Charbonnier, A. A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission. Blood (2012) 120: 4317–23. DOI: 10.1182/blood-2012-06-437558 PMID: 23002117

references

• https://w3id.org/oc/corpus/br/1912384